LICN LICN
Company Profile ↓Company Overview
LICN (LICN) is a publicly traded company listed on with a market capitalization of $18.29M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $24.52M (-40.9% YoY); net profit $-21.96M.
- Trailing 12 Months Year-on-year growth — revenue -40.9%.
- 5-Year Trend Long-term compounding — revenue CAGR -10.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -10.15% |
| 1 Year: | -40.89% |
Stock Price Performance
| 1 Year: | -71.50% |
| 6 Months: | -62.67% |
| 3 Months: | -74.25% |
| 1 Month: | -30.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.21 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -10.2% CAGR over 5 years.
- Trading 87.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 33.80M | 39.76M | 41.48M | 24.52M |
| Cost of Revenue | - | 13.61M | 15.44M | 15.80M | 15.38M |
| Gross Profit | - | 20.19M | 24.32M | 25.67M | 9.14M |
| Operating Expenses | - | 9.54M | 12.06M | 30.23M | 23.54M |
| Operating Income | - | 10.65M | 12.26M | -4.55M | -14.41M |
| EBITDA | - | 13.33M | 15.18M | -1.68M | -10.26M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | 10.74M | 11.59M | -4.17M | -21.79M |
| Tax Provision | - | 2.92M | 3.25M | 1.95M | 0 |
| Net Income | - | 7.82M | 8.34M | -6.14M | -21.96M |
| Diluted EPS | 63.86 | 54.39 | 63.96 | -34.79 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 46.52M | 65.55M | 79.84M | 75.57M |
| Current Assets | - | 27.27M | 40.13M | 34.01M | 36.17M |
| Cash & Equivalents | - | 22.60M | 25.86M | 26.71M | 26.91M |
| Inventory | - | 127.00K | 87.00K | 67.00K | 0 |
| Receivables | - | 3.12M | 3.66M | 3.55M | 1.97M |
| Total Liabilities | - | 5.42M | 4.12M | 4.28M | 5.02M |
| Current Liabilities | - | 5.23M | 4.09M | 4.27M | 4.68M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 272.00K | 129.00K | 61.00K | 554.00K |
| Total Equity | - | 41.11M | 61.42M | 73.18M | 70.55M |
| Shares Outstanding | - | 132.50K | 132.50K | 435.50K | 16.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 10.77M | 557.00K | -5.57M | -17.85M |
| Investing Cash Flow | - | -2.84M | -9.87M | -9.89M | -5.48M |
| Financing Cash Flow | - | -327.00K | 14.10M | 13.09M | 23.61M |
| Capital Expenditure | -28.00K | -2.84M | -9.87M | -5.93M | - |
| Free Cash Flow | - | 7.92M | -9.31M | -11.51M | -17.85M |
| Net Change in Cash | - | 7.60M | 4.79M | -2.37M | 285.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 59.7% | 61.2% | 61.9% | 37.3% |
| Operating Margin % | - | 31.5% | 30.8% | -11.0% | -58.8% |
| Net Margin % | - | 23.1% | 21.0% | -14.8% | -89.6% |
| ROE % | - | 19.0% | 13.6% | -8.4% | -31.1% |
| ROCE % | - | 25.8% | 19.9% | -6.0% | -20.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LICN
Lichen International Limited Announces Financial Results for Fiscal Year 2025
XIAMEN, China, April 28, 2026 (GLOBE NEWSWIRE) -- Lichen International Limited (Nasdaq: LICN) ("Lichen International" or the "Company"), a dedicated financial and taxation service provider in China today announced its financial results for …
LICN — Frequently Asked Questions
What is the current share price of LICN?
As of 2026-08-05 17:25 PDT, LICN trades at $1.12 on NASDAQ/NYSE. Its 52-week range is $0.84 to $8.63.
What is the market capitalisation of LICN?
LICN has a market capitalisation of $18.29M on NASDAQ/NYSE.
What is the P/E ratio of LICN?
LICN trades at a trailing price-to-earnings (P/E) ratio of -0.03. Its price-to-book (P/B) ratio is 0.26.
What is the return on equity (ROE) of LICN?
LICN has a return on equity (ROE) of -31.13%. Its return on capital employed (ROCE) is -20.32%.
Is LICN a good stock to buy?
This page provides a data-driven analysis of LICN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.